TWIST BIOSCIENCE ($TWST) posted quarterly earnings results for Q1 2026 on Monday, February 2nd. The company reported earnings of -$0.50 per share, missing estimates of -$0.44 by $0.06. The company also reported revenue of $103,700,000, beating estimates of $102,818,040 by $881,960.
You can see Quiver Quantitative's $TWST stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TWIST BIOSCIENCE Insider Trading Activity
TWIST BIOSCIENCE insiders have traded $TWST stock on the open market 63 times in the past 6 months. Of those trades, 0 have been purchases and 63 have been sales.
Here’s a breakdown of recent trading of $TWST stock by insiders over the last 6 months:
- PATRICK JOHN FINN (President and COO) has made 0 purchases and 10 sales selling 79,028 shares for an estimated $2,705,285.
- EMILY M. LEPROUST (Chief Executive Officer) has made 0 purchases and 11 sales selling 86,883 shares for an estimated $2,700,762.
- ADAM LAPONIS (Chief Financial Officer) has made 0 purchases and 8 sales selling 24,452 shares for an estimated $802,779.
- PAULA GREEN (SVP of Human Resources) has made 0 purchases and 11 sales selling 22,677 shares for an estimated $706,331.
- DENNIS CHO (See Remarks) has made 0 purchases and 12 sales selling 14,915 shares for an estimated $461,790.
- ROBERT F. WERNER (Chief Accounting Officer) has made 0 purchases and 10 sales selling 6,010 shares for an estimated $181,133.
- JAN JOHANNESSEN sold 7,044 shares for an estimated $174,479
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TWIST BIOSCIENCE Hedge Fund Activity
We have seen 138 institutional investors add shares of TWIST BIOSCIENCE stock to their portfolio, and 99 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EDGEPOINT INVESTMENT GROUP INC. added 1,696,377 shares (+71.1%) to their portfolio in Q3 2025, for an estimated $47,736,048
- POINT72 ASSET MANAGEMENT, L.P. removed 1,628,357 shares (-75.4%) from their portfolio in Q3 2025, for an estimated $45,821,965
- SOLEUS CAPITAL MANAGEMENT, L.P. added 1,511,833 shares (+426.6%) to their portfolio in Q3 2025, for an estimated $42,542,980
- THRIVENT FINANCIAL FOR LUTHERANS added 1,456,368 shares (+21681.8%) to their portfolio in Q3 2025, for an estimated $40,982,195
- CITADEL ADVISORS LLC removed 1,388,301 shares (-92.3%) from their portfolio in Q3 2025, for an estimated $39,066,790
- ARTISAN PARTNERS LIMITED PARTNERSHIP added 1,349,867 shares (+26.7%) to their portfolio in Q3 2025, for an estimated $37,985,257
- MILLENNIUM MANAGEMENT LLC added 1,080,722 shares (+151.5%) to their portfolio in Q3 2025, for an estimated $30,411,517
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TWIST BIOSCIENCE Analyst Ratings
Wall Street analysts have issued reports on $TWST in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 11/17/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
To track analyst ratings and price targets for TWIST BIOSCIENCE, check out Quiver Quantitative's $TWST forecast page.
TWIST BIOSCIENCE Price Targets
Multiple analysts have issued price targets for $TWST recently. We have seen 5 analysts offer price targets for $TWST in the last 6 months, with a median target of $42.0.
Here are some recent targets:
- Subbu Nambi from Guggenheim set a target price of $79.0 on 01/26/2026
- Brendan Smith from TD Cowen set a target price of $43.0 on 01/08/2026
- Luke Sergott from Barclays set a target price of $39.0 on 12/15/2025
- Steven Etoch from Stephens & Co. set a target price of $41.0 on 11/04/2025
- Vijay Kumar from Evercore ISI Group set a target price of $42.0 on 10/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
